Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Medicare Planning

FAQ: Medicare Scope of Appointment Forms

Your article was successfully shared with the contacts you provided.

An agent from Markham, TX asks…

Q: On Medicare Advantage plans, we need a scope-of-appointment form before we meet with Medicare customers. How about meeting a customer for a Medicare supplement; do we need a scope-of-appointment form also?

A: You do not need a scope-of-appointment to market/sell/enroll a Medicare beneficiary in a Med supp plan. As scope-of-appointment form (SOA) is only required if you are discussing Medicare Part C or Part D products. However, to do a proper fact finding interview, we recommend an SOA be signed at the beginning of each sale. No presentation is complete unless you discuss their current PDP or Part D status. When dealing with CMS (or any government agency), we always advise brokers to be safe and get the SOA signed anyway. We also advise brokers to record the interview on a digital recorder. While this may seem like compliance overkill, we have been able to clear any allegations against a broker when the recorded interview presents the other side of the story.

Our Medicare expert is Mike Smith, president of The Brokerage Inc. He can be reached at [email protected] or 469-635-6703.

If you would like to be considered for our Medicare FAQ expert panel to answer frequently asked questions, email associate editor Heather Trese.

Do you have a Medicare question that you would like answered? Email us and let us know! Please put “Medicare FAQ” in the subject line.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.